Table: q1_q4_2021_prescription_drug_wac_increases , manufacturer_name like O*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982085003 Octagam 10% Vial 100Ml/10g 10/01/2021 69.00 1796.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=575, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=584 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982085004 Octagam 10% Vial 200Ml/20g 10/01/2021 138.00 3592.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=576, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=585 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982085001 Octagam 10% Vial 20Ml/2g 10/01/2021 13.80 359.20 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=573, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=582 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982085005 Octagam 10% Vial 300Ml/30g 10/01/2021 207.00 5388.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=577, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=586 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982085002 Octagam 10% Vial 50Ml/5g 10/01/2021 34.50 898.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=574, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=583 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982084001 Octagam 5% Vial /1g 10/01/2021 6.90 179.60 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=569, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=578 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982084003 Octagam 5% Vial 100Ml/5g 10/01/2021 34.50 898.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=571, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=580 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982084004 Octagam 5% Vial 200Ml/10g 10/01/2021 69.00 1796.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=572, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=581 None
Rx0000249 Octapharma USA, Inc. 12/31/2021 68982084002 Octagam 5% Vial 50Ml/2.5g 10/01/2021 17.25 449.00 None Innovator Multiple Source Drug None 1 "Increases in US source plasma costs and manufacturing costs resulted in the price increase for the product." None "No change or improvement to the product necessitated the price increase. Please refer to Cost Increase Factor statement" None None None None None None None None None None https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=570, https://reports.siera.oshpd.ca.gov/api/report/drug-pricing/attachment?id=579 None
Rx0000234 Optinose US, Inc. 03/31/2021 71143037501 Fluticasone Propionate (Nasal) 93 MCG/ACT Exhaler Suspension, 1 Exhaler of 16 ML 01/01/2021 28.34 542.97 07/07/2035 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None The product was not acquired within the last 5 years.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008213 JYNARQUE® (tolvaptan) 15 mg tablets, bottle of 30 01/15/2021 563.43 8612.44 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148007928 JYNARQUE® (tolvaptan) 15 mg/15 mg tablets, 4 x 14 weekly blister packs 01/15/2021 1051.74 16076.56 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008313 JYNARQUE® (tolvaptan) 30 mg, bottle of 30 01/15/2021 563.43 8612.44 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008028 JYNARQUE® (tolvaptan) 30 mg/15 mg tablets, 4 x 14 weekly blister packs 01/15/2021 1051.74 16076.56 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008728 JYNARQUE® (tolvaptan) 45 mg/15 mg tablets, 4 x 14 weekly blister packs 01/15/2021 1051.74 16076.56 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008828 JYNARQUE® (tolvaptan) 60 mg/30 mg tablets, 4 x 14 weekly blister packs 01/15/2021 1051.74 16076.56 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148008928 JYNARQUE® (tolvaptan) 90 mg/30 mg tablets, 4 x 14 weekly blister packs 01/15/2021 1051.74 16076.56 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None JYNARQUE® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148002050 SAMSCA® (tolvaptan) 15 mg tablets, blister pack of 10 01/15/2021 247.71 5201.97 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None SAMSCA® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000067 Otsuka America Pharmaceutical, Inc. 03/31/2021 59148002150 SAMSCA® (tolvaptan) 30 mg tablets, blister pack of 10 01/15/2021 256.97 5396.43 04/07/2030 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None SAMSCA® is protected by an additional patent listed in FDA Orange Book with an expiration date of 9/1/2026.
Rx0000192 OWP Pharmaceuticals, Inc. 03/31/2021 69102013710 Lamotrigine USP Orange Starter Kit, (42) 25mg Tablets & (7) 100mg Tablets 03/01/2021 31.00 648.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000192 OWP Pharmaceuticals, Inc. 03/31/2021 69102030001 Subvenite (lamotrigine USP) Orange Starter Kit, (42) 25mg Tablets & (7) 100mg Tablets 03/01/2021 31.00 648.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None